NCT01392924View on ClinicalTrials.gov

Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

November 30, 2014

Conditions

Neoplasm Malignant

Interventions

DRUG

SAR245408

Pharmaceutical form: tablet Route of administration: oral

Trial Locations (2)

Unknown

Investigational Site Number 392002, Kobe

Investigational Site Number 392001, Nagoya

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY